Sentences with phrase «findings against a vaccine»

What surprises many scientists is that their findings against a vaccine connection keep failing to quell the debate, giving the antivaccine movement the potential to become a genuine public - health problem.

Not exact matches

In essence, the HPV vaccine will continue to be advised against during pregnancy until more research confirms what this study has found.

Find out all you need to know about the chicken pox vaccine, how completely it protects against chicken pox, and whether it als...

Find out how the MMR vaccine can protect your child against measles, mumps, and rubella (German measles), and the recommended i...

Find out how the pneumococcal vaccine protects young kids against some of the worst childhood diseases, including meningitis an...

Find out how the polio vaccine can protect your child against a sometimes devastating virus, and the recommended immunization s...

322 Additional subsequent large population case - control trials consistently have found vaccines to be protective against SIDS323, — , 325; however, confounding factors (social, maternal, birth, and infant medical history) might account for this protective effect.326 It also has been theorized that the decreased SIDS rate immediately after vaccination was attributable to infants being healthier at time of immunization, or «the healthy vaccinee effect.»

At first he worked on a vaccine against Chagas disease, but then he noticed some recent findings made by other researchers in the lab.

Researchers are trying to find out if a vaccine against meningitis B, caused by related bacteria, might cause some cross-immunity to gonorrhoea.

Based on their findings, they urge that «mosquito saliva and enhancing antibodies thus need to be considered when developing vaccines and drugs against dengue,» and specifically suggest that «animal models of dengue and pre-clinical validation of dengue vaccine candidates should be evaluated in the combined presence of mosquito saliva and enhancing antibodies.»

In a preliminary study published in the April Journal of the American Medical Association, the researchers found that the vaccine produced by this method protects against the two strains to which the subjects were exposed and most likely protects against the third.

This finding also paves the way for practical applications: the ETH spin - off Malcisbo, which came from the microbiologist's laboratory, endeavours, on the basis of these surface sugar structures to develop novel vaccines against parasites and pathogenic germs for livestock and humans.

«It was not known whether any of these vaccines could provide protection against the new outbreak West African Makona strain of Ebola Zaire currently circulating in Guinea,» said John Eldridge, Chief Scientific Officer - Vaccines at Profectus Biosciences, Inc. «Our findings show that our candidate vaccines provided complete, single dose protection from a lethal amount of the Makona strain of Ebola virusvaccines could provide protection against the new outbreak West African Makona strain of Ebola Zaire currently circulating in Guinea,» said John Eldridge, Chief Scientific Officer - Vaccines at Profectus Biosciences, Inc. «Our findings show that our candidate vaccines provided complete, single dose protection from a lethal amount of the Makona strain of Ebola virusVaccines at Profectus Biosciences, Inc. «Our findings show that our candidate vaccines provided complete, single dose protection from a lethal amount of the Makona strain of Ebola virusvaccines provided complete, single dose protection from a lethal amount of the Makona strain of Ebola virus.»

Yet there is reason for optimism: the NIH has already developed a DNA vaccine against the West Nile virus that appeared promising in early human studies (although ultimately the NIH could not find a commercial partner to take that vaccine forward).

Remarkably, the researchers also found that blocking this protein in mice protected them from the lethal effects of dengue virus infection, an important finding given that an effective vaccine against dengue has remained elusive, partly because there are four serotypes of the virus that cause disease.

Adjuvanted vaccines in particular were found to be more effective in children than in adults against laboratory confirmed illness (88 per cent in children versus 40 per cent in adults) and hospitalisation (86 per cent in children versus 48 per cent in adults).

She found that the weakened sporozoites triggered immunity against malaria instead of the disease, paving the way for a potential vaccine.

«We found that the vaccines produced against the swine flu pandemic in 2009 were very effective in both preventing influenza infection and reducing the chances of hospital admission due to flu.

«The microgravity environment of the International Space Station is now being used for myriad lines of research, for example: vaccine development, finding novel molecular targets against drug - resistant pathogens, and testing of molecules to be used against osteoporosis or cancer,» Zea says.

Currently, seasonal flu vaccines are designed to induce high levels of protective antibodies against hemagglutinin (HA), a protein found on the surface of the influenza virus that enables the virus to enter a human cell and initiate infection.

Seoul — Progress in finding vaccines against the leading killers in the developing world will require greater attention to the needs of those countries, says a group of scientists who are helping to launch the International Vaccine Institute in Seoul

The researchers, led by Ram Sasisekharan, the Alfred H. Caspary Professor of Biological Engineering at MIT, also found that current flu vaccines might not offer protection against these strains.

An experimental vaccine against the MERS virus triggers immune protection, a new study finds.

Foot - and - mouth disease is of great economic importance and their findings could lead to the development of more effective vaccines against the disease in the future.

«The findings from this trial are very encouraging to those of us who have spent many years working on vaccine candidates to protect against dengue, a disease that is a significant burden in much of the world and is now endemic in Puerto Rico,» said Stephen Whitehead, Ph.D., of NIH's National Institute of Allergy and Infectious Diseases (NIAID).

In a 2011 vaccine trial of patients whose primary pancreatic tumors were surgically removed, «we found antibodies against annexin A2 in those who had received the vaccine and who also had demonstrated long - term, disease - free survival after receiving the vaccines,» explains Zheng.

In August, Berkley, who founded and heads the International AIDS Vaccine Initiative (IAVI), will take over the GAVI Alliance, another public - private partnership focused on vaccines but with the broader agenda of immunizing children in poor countries against many diseases.

A vaccine that protects against the virus that causes Middle East respiratory syndrome (MERS) has been shown to be effective in camels, a new study finds.

A new study finds that a simple reminder via electronic health record systems may go a long way in encouraging patients to get the HPV vaccine that protects against cervical cancer.

«The immune responses are there, the tough call is whether they're enough to protect humans against Ebola, and I guess we'll find that out in the phase 3 trial,» says Adrian Hill, director of the Jenner Institute in Oxford, UK, who is leading a small safety trial of the monovalent NIAID / GSK vaccine.

Reported in the January 16, 2015 issue of the journal Science, the new findings provide a cautionary tale for the development of vaccines aimed at eliciting robust CD4 T cell immunity against chronic infections, including HIV.

The researchers» find means that current diagnostic methods, vaccines, and other treatment interventions should remain effective against the virus.

The finding is exciting «because it suggests that the seasonal flu vaccine boosts antibody responses and may provide some measure of protection against a new pandemic strain that could emerge from the avian population,» said senior study author Paul G. Thomas, PhD, an Associate Member in the Department of Immunology at St. Jude.

The work, directed by researchers at St. Jude Children's Research Hospital in Memphis, Tenn., found that some study participants who reported receiving flu vaccines had a strong immune response not only against the seasonal H3N2 flu strain from 2010, when blood samples were collected for analysis, but also against flu subtypes never included in any vaccine formulation.

They also suggest their findings point to the possibility of combining protective antibodies with an eventual vaccine, which could synergistically provide more a robust level of protection against Zika.

Moreover, they found that distinct HA mutations are evolving in the H7N9 virus indicating that currently recommended H7 vaccines would not be effective against this newly emerged virus.

That finding supports the idea that the measles vaccine benefits children not just because it prevents them from getting measles, but also because it provides protection against the other diseases.

«Right now, there is no vaccine to protect against the H7N9 virus, and our findings could guide efforts to develop effective vaccine strategies,» Sasisekharan says.

The latest data from a large clinical trial of Merck's cervical cancer vaccine, Gardasil, found it offered 100 % protection against cervical, vulval and vaginal diseases, caused by HPV (types 6, 11, 16 and 18) and 98 % protection against advanced pre-cancers caused by HPV types 16 and 18 (New England Journal of Medicine: vol 356, p1915).

Most other vaccine trials have tried to use the malaria parasite — rather than the body's reaction against it — to find possible targets for vaccines.

The researchers found that the personal vaccine induced a focused T cell response against several tumor neoantigens, beyond what is normally seen in response to existing immunotherapies.

Crafting a vaccine against RSV (respiratory syncytial virus) has been a minefield for 50 years, but scientists believe they have found the right balance.

It was founded in November 2005 to develop innovative vaccines against major global diseases.

But Balin says that attempts to create vaccines against strains of herpes and chlamydia found in the brains of Alzheimer's patients have proven difficult, and there's nothing currently on the horizon.

Discrimination against entire subgroups could also occur if, for example, genetic variants were found to correlate with a more favorable vaccine or treatment response, but only in certain ethnic groups; also, drug development might focus on these «more responsive subgroups.

«In the future, [the findings] could apply to vaccines that we hope will be developed against generally lethal viruses (e.g. HIV, Ebola), encouraging scientists to strive towards «perfect vaccines» for them,» Michael Skinner, a virologist from Imperial College London who wasn't part of the study, told the Science Media Centre.

'» In all patients who were vaccinated, his team found tumor - targeting T cells, and he noted that in addition to augmenting pre-existing T cell responses, the vaccine also stimulated new T cell responses against tumors.

The findings are published this week in the Proceedings of the National Academy of Sciences (PNAS) and provide the foundation for future antiviral drug and vaccine development against the virus, rhinovirus C.

«We're highly encouraged by these preclinical findings demonstrating the ability of our mRNA vaccine to provide robust prevention of maternal transmission of Zika and protection against congenital defects,» said Giuseppe Ciaramella, Ph.D., Chief Scientific Officer of Moderna's infectious disease - focused venture, Valera, and an author on the paper.

The study relates to a particular type of vaccine (killed) against a particular virus, influenza, though the findings might hold true for other killed vaccines and for those vaccines consisting only of proteins produced by GM in bacteria, yeast or insect cells, against diseases such as hepatitis B (HBV) and human papilloma virus (HPV, the causative agent of cervical cancer).